PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7901689

Field tests for rational drug use in twelve developing countries.

H V Hogerzeil·Bimo·D Ross-Degnan·R O Laing·D Ofori-Adjei·B Santoso·A K Azad Chowdhury·A M Das·K K Kafle·A F Mabadeje
View original source ↗Export metadata ↓

Abstract

Increasing efforts are being made to improve drug-use practices and prescribing behaviour in developing countries. An essential tool for such work is an objective and standard method of assessment. We present here a set of drug-use indicators produced and tested in twelve developing countries. We describe practical applications, which include the use of indicators to increase awareness among prescribers in Malawi and Bangladesh, to identify priorities for action (eg, polypharmacy in Indonesia and Nigeria, overuse of injections in Uganda, Sudan, and Nigeria, and low percentage of patients who understood the dosage schedule in Malawi), and to quantify the impact of interventions in Yemen, Uganda, Sudan, and Zimbabwe.

Explore related subjects

Developing CountriesDrug PrescriptionsDrug TherapyDrug UtilizationDrug Utilization ReviewHumansPractice Patterns, Physicians'AntibioticsData CollectionDelivery Of Health CareDistributional ActivitiesDrugsHealthHealth FacilitiesOral RehydrationOrganization And AdministrationPrescriptions--standardsProgram ActivitiesProgramsResearch MethodologyRural Health CentersTreatmentJournal ArticleResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H V Hogerzeil, Bimo, D Ross-Degnan, R O Laing, D Ofori-Adjei, B Santoso, A K Azad Chowdhury, A M Das, K K Kafle, A F Mabadeje. 1993-12-04. Field tests for rational drug use in twelve developing countries.. https://doi.org/10.1016/0140-6736(93)92760-q

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Costs of surgeries in low- and middle-income countries: a systematic literature review.

BACKGROUND: Surgical care is essential for achieving global health equity, yet low- and middle-income countries (LMICs) face major gaps in access and planning, partly due to limited evidence on the costs and resource requirements of surgical interventions. Understanding these costs is vital for designing efficient and equitable health systems. METHODS: We conducted a systematic literature review (covering MEDLINE, EMBASE, Global Health, EconLit and grey literature) to identify studies reporting the costs of surgeries in LMICs from January 2000 to June 2023. Minor and major surgical procedures were considered, focusing on therapeutic procedures (excluding diagnostic interventions). Studies that clearly identified, quantified and costed hospital resources and services deployed in the provision of surgical care, and included at least two of the surgical production factors (ie, consumables, diagnostics, personnel, infrastructure and overhead) in the costing were included. Costs were standardised to 2023 International dollars (I$) for comparability. RESULTS: A total of 74 studies from 29 countries met the inclusion criteria, with 210 cost estimates across 65 procedure groups. Costs varied widely: from I$1.54 for a caesarean section in Tanzania to I$618 098 for paediatric cataract surgery in Zambia. Full costing studies reported higher estimates than partial costing studies. Most studies (60%) originated from upper-middle-income countries, with limited data (10%) from low-income settings. CONCLUSION: This review provides a reference list of surgical procedure costs across LMICs, highlighting considerable cost variation by procedure, specialty and country. The findings underscore the need for better-quality, standardised cost data-especially from low-income countries-to inform national surgical plans, universal health coverage benefit packages and reimbursement policies.

Developing Countries↗